NCT01908582View on ClinicalTrials.gov

A Study of Evacetrapib and Rifampin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

Administered orally

DRUG

Rifampin

Administered orally

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01908582 - A Study of Evacetrapib and Rifampin in Healthy Participants | Biotech Hunter | Biotech Hunter